National Academy of Medicine

It’s Time to Harmonize Clinical Trial Site Standards

Climbing costs and lengthy time frames of clinical trials are significant bottlenecks in medical product development. Despite the fact that scientifi
Read More

Manufacturing Cell Therapies: The Paradigm Shift in Health Care of This Century

  Recent advances in cell biology and genetic engineering have changed the way we think about medicine. Indeed, we are wit
Read More

Essential Stewardship Priorities for Academic Health Systems

In “Essential Stewardship Priorities for Academic Health Systems,” the CEOs of five leading academic centers &
Read More

Public Health Laboratories in an Age of Austerity

The complex public health laboratory (PHL) system in the United States provides and assures a wide range of services and activities.
Read More

Making the Case for Continuous Learning from Routinely Collected Data

In “Making the Case for Continuous Learning from Routinely Collected Data,” the authors suggest that
Read More

Toward Realizing an Ideal National Biosurveillance System

In October 2007, HSPD 21 called for a nationwide biosurveillance capability. Biosurveillance “in the context of human health
Read More

Canadian Strategy on Patient-Oriented Research

In Canada, as elsewhere, the translation of health research outcomes to development of products and services for health care and final i
Read More

Novel Ways to Get Good Trial Data: The UK Experience

Traditional randomised clinical trials are very expensive and time-consuming and often have poor external validity (Ware and Hamel,
Read More

Health Research as a Public Good

The arrangements for the regulation and governance of health research in the United Kingdom (UK) have evolved, piecemeal, over the past 30 years, and
Read More